Current Topics in Medicinal Chemistry

ISSN: 1568-0266 - Volume 8, 18 Issues, 2008

Editor-in-Chief:

Allen B. Reitz
Alsgen, Inc.,
One Deer Park Dr., Suite L-1
Monmouth Junction, NJ 08852
USA
Tel: +1- 215-264-4287
Email: reitz12000@yahoo.com

Associate Editor:

C. Lindsley
Vanderbilt University, Nashville, TN
USA

Editorial Advisory Board:

M.A. Abou-Gharbia (Wyeth Research, Princeton, NJ, USA)
J. Adams (Univ. of Southern California, Los Angeles, CA, USA)
M.J. Alcazar (Johnson & Johnson Pharmaceutical Res. & Devel., Toledo, Spain)
J. Aube (Univ. of Kansas, Lawrence, KS, USA)
M. Avery (University of Mississippi, University, MS, USA)
B.N. Balasubramanian (Bristo-Myers Squibb, Princeton, NJ, USA)
T.R. Beattie (Consultant, San Diego, CA, USA)
P.R. Bernstein (AstraZeneca, Wilmington, DE, USA)
R. Bicca de Alancastro (Univ.-Ilha do Fundao, Rio de Janeiro, Brazil)
W.J. Brouillette (University of Alabama at Birmingham, Birmingham, AL, USA)
G.W. Caldwell (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
M.J. Camarasa (Instituto de Quimica Medica (CSIC), Madrid, Spain)
F.I. Carroll (Research Triangle Institute, Research Triangle Park, NC, USA)
N. Carruthers (Johnson & Johnson Pharmaceutical Res. & Devel., San Diego, CA, USA)
D. Comins (North Carolina State University, Raleigh, NC)
J.M. Cook (Univ. of Wisconsin, Milwaukee, WI, USA)
J. Cossy (ESPCOI, Paris, France)
A.K. Debnath (Lindsley F. Kimball Res. Inst., New York, NY, USA)
B. Deprez (Faculte de Pharmacie de Lille, Lille, France)
M.C. Desai (Gilead Sciences, Inc., Forster City, CA, USA)
R.H. Dodd (Institute de Chimie des Substances Naturelles, Gif-Sur-Yvette, France)
A. Espinosa (Facultad de Farmacia, Granada, Spain)
M. Fernandez Zertuche (Univ. Autonoma Del Edo. De Morelos, Morelos, Mexico)
G.I. Georg (Univ. of Kansas, Lawrence, KS, USA)
S.W. Gerritz (Glaxo SmithKline, Research Triangle Park, NC, USA)
C. Gilon (The Hebrew University, Jerusalem, Israel)
R. Giuliano (Villanova University, Villanova, PA USA)
R.A. Glennon (Virginia Commonwealth Univ., Richmond, VA, USA)
M.J. Green (Celera, South San Francisco, CA USA)
G. Hartman (Merck Research Labortories, West Point, PA, USA)
P.R. Hanson (Univ. of Kansas, Lawrence, KS, USA)
Y. Hashimoto (Univ. of Tokyo, Tokyo, USA)
P.A. Hipskind (Lilly Research Laboratories, Indianapolis, IN, USA)
W.J. Hoekstra (Glaxo SmithKline, Research Triangle Park, NC, USA)
V.J. Hruby (Univ. of Arizona, Tucson, USA)
R.L. Hudkins (Cephalon, Inc., West Chester, PA, USA)
D. Huryn (University of Pennsylvania, Philadelphia, PA, USA)
K.A. Jacobson (National Institute of Health, Bethesda, MD, USA)
F. Janssens (Johnson & Johnson Pharmaceutical Res. & Devel., Beerse, Belgium)
A.D. Jordan (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
M.M. Joullie (University of Pennsylvania, Philadelphia, USA)
E. Juaristi (CINVESTAV-IPN, Mexico, Mexico)
M.E. Jung (University of California Los Angeles, Lose Angels, CA, USA)
D. Kimball (Lexicon Pharmaceuticals, Princeton, NJ, USA)
M. Koufaki (Institute of Organic and Pharmaceutical Chemistry, Athens, Greece)
A.P. Kozikowski (University of Illinois at Chicago, Chicago, IL, USA)
R.L. Li (Peking University, Beijing, China)
J.A. Lowe (Pfizer, Inc., Croton, CT, USA)
W.D. Lubell (Universite de Montreal, Montreal, Quebec, Canada)
J.I.Luengo (Glaxo SmithKline, Collegeville, PA USA)
G. MacDonald (Johnson & Johnson Pharmaceutical Res. & Devel., Beerse, Belgium)
M. Macielag (Johnson & Johnson Pharmaceutical Res. & Devel., Raritan, NJ, USA)
J.E. Macor (Bristol-Myers Squibb, Wallingford, CT, USA)
J. Major (Cellzome, Cambridge, UK)
B.E. Maryanoff (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
O.R. Martin (Universite d’Orleans, Orleans, France)
R. Mata (Facultad de Quimica, Univ. Nac. Auton. De Mexico, Mexico City, Mexico)
C.R. McCurdy (University of Mississippi, University, MS, USA)
W.F. Michne (Dolphin road, Oriental, USA)
D.D. Miller (University of Tennessee, Memphis, TN, USA)
G. Molander (University of Pennsylvania, Philadelphia, PA, USA)
M. Murcko (Vertex Pharmaceuticals, Cambridge, MA, USA)
R.P. Nargund (Merck Research Laboratories, Rahway, NJ, USA)
N. Neamati (Univ. of Southern California, Los Angels, CA, USA)
M.H. Norman (Amgen, Inc., Thousand Oaks, CA, USA)
I.Ojima (State University of New York, Stony Brook, NY, USA)
R. Pellicciari (Univ. di Perugia, Perugia, Italy)
Z. Rankovic (Organon Research, Scotland, UK)
K.C. Rice (National Institute of Health, Bethesda, MD, USA)
J. A. Secrist, III (Southern Research Institute, Birmingham, AL, USA)
S.M. Sieburth (Temple University, Philadelphia, PA, USA)
B.B. Snider (Brandeis University, Waltham, MA, USA)
S. Street (Pfizer Global Res. & Devel., Sandwich, UK)
A. Thurkauf (Achillion Pharmaceutical, New Haven, CT, USA)
B. Tomczuk (Johnson & Johnson Pharmaceutical Res. & Devel., Spring House, PA, USA)
J.P. Vacca (Merck Research Laboratories, West Point, PA, USA)
J.W.F. Wasley (Simpharma, LLC, Guilford, CT, USA)
F. Wilson (Cellzome, Cambridge, UK)
D.J.Wustrow (Pfizer Global Research & Development, Ann Arbor, MI, USA)
L. Zhang (Peking University, Beijing, China)
N.Z. Zeirov (Moscow State University, Lenin Hills, Moscow, Russia)